Epigral Ltd. (EPIGRAL) Share Price rises 8.25% as stock gains today

Published: 24 August 2026 at 11:19:19 AM IST

Epigral Ltd. Share Price rose to Rs 1,217.50 today, up 8.25% from the previous close of Rs 1,124.70, while the company’s market capitalisation stood at Rs 4,852.11 crore. The move makes Epigral a notable name in today’s share market update and places it among the stocks in news on the Indian stock market. The verified data confirms a same-day price rise, but it does not establish a company-specific catalyst. For readers following Epigral Ltd. Stock News, the most relevant checks are the day’s price action, valuation ratios, and how the company compares with chemicals sector peers on Univest.

The session opened at Rs 1,130.20, touched an intraday high of Rs 1,223 and a low of Rs 1,125.05. Turnover stood at Rs 1.27 crore. That combination shows a clear upward move in Epigral Ltd. Share Price Today, but the dataset itself only confirms the price event and trading metrics; it does not identify a reason. Univest tracks this kind of share price rise alongside valuation and sector context so investors can read the event in a broader market framework.

The price behaviour also indicates that the stock spent most of the session near the upper end of its range. The gap between the opening price and the day’s high was limited, which suggests the move was sustained rather than a brief spike. For Epigral Ltd. Share Price watchers, that is important because it places the rise in the context of a full trading session, not only the closing price.

Because the company’s current price is above the previous close by Rs 92.80, the market has already repriced the stock meaningfully in a single day. Still, the data provided here does not explain whether the move reflects investor sentiment, news flow or broader market rotation. This article therefore focuses on the confirmed market data and the valuation backdrop that can be measured objectively.

Epigral Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,217.5
Previous Close	Rs 1,124.7
Today's Move	Rs 92.8 (+8.25%)
Open	Rs 1,130.2
High	Rs 1,223
Low	Rs 1,125.05
Turnover	Rs 1.27 crore
Market Capitalisation	Rs 4,852.11 crore
Market Cap Category	Small Cap

Epigral Ltd. (EPIGRAL) rose to Rs 1,217.5 from the previous close of Rs 1,124.7, a move of Rs 92.8 or 8.25%. The stock opened at Rs 1,130.2, reached a high of Rs 1,223, recorded a low of Rs 1,125.05.

Epigral Ltd. Share Price Today gained Rs 92.80, or 8.25%, from Rs 1,124.70 to Rs 1,217.50. The stock opened at Rs 1,130.20, moved between Rs 1,125.05 and Rs 1,223, and closed well above the previous close in the supplied move. The price rise is a factual same-day event; the data does not assign a cause. On Univest, this type of Epigral Ltd. Share Price Update is best read together with market cap, turnover and company fundamentals rather than treated as a stand-alone signal.

The fact that the stock also printed an intraday high of Rs 1,223 means it came very close to the top of its session range. That is useful for readers because it shows the price rise was not confined to the opening minutes. Instead, the Epigral Ltd. Share Price held firm through the day within the data supplied.

Turnover of Rs 1.27 crore adds a market activity reference point for the session, though it should not be read as a reason for the rise. Combined with the day’s low of Rs 1,125.05 and the close of Rs 1,217.50, the move reflects a strong upward drift from the opening level and a finish near the session high.

Epigral Ltd. (EPIGRAL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,852.11 crore
P/E Ratio	17.9x
P/B Ratio	2.09x
ROE	16.09%
ROCE	15.65%
EPS	Rs 62.82
Book Value Per Share	Rs 537.91
Dividend Yield	0.44%

Epigral Ltd. (EPIGRAL) fundamental metrics show P/E 17.9x, P/B 2.09x, ROE 16.09%, ROCE 15.65%. These figures provide context only and are not a buy or sell signal.

Epigral Ltd. has a market capitalisation of Rs 4852.11 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.9x, P/B at 2.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.09% and ROCE of 15.65%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 62.82, book value per share of Rs 537.91, dividend yield of 0.44%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 24.67x, median ROE of 7.73%, median ROCE of 9.93%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Company P/E Ratio	17.9x
Benchmark Median P/E	24.67x
Benchmark Average P/E	46.22x
Benchmark P/E Range	4.32x to 750.68x
Company P/B Ratio	2.09x
Benchmark Median P/B	1.88x
Company ROE	16.09%
Benchmark Median ROE	7.73%
Company ROCE	15.65%
Benchmark Median ROCE	9.93%
Company Market Capitalisation	Rs 4,852.11 crore
Benchmark Median Market Cap	Rs 498.99 crore

Epigral Ltd. (EPIGRAL) is classified under sector: Chemicals and industry: Chemicals.

Epigral Ltd. (EPIGRAL) has a P/E ratio of 17.9x, which is below the benchmark median of 24.67x, a difference of -27.44%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Epigral Ltd. (EPIGRAL) has a ROE of 16.09%, which is above the benchmark median of 7.73%, a difference of +108.15%. Epigral Ltd. (EPIGRAL) has a ROCE of 15.65%, which is above the benchmark median of 9.93%, a difference of +57.6%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solar Industries India Ltd.	SOLARINDS	1,80,142.17	90.46	25.98	32.49	38.16
Pidilite Industries Ltd.	PIDILITIND	1,67,461.57	63.22	14.48	24.29	32.38
SRF Ltd.	SRF	76,372.37	35.33	5.17	13.8	14.21
Gujarat Fluorochemicals Ltd.	FLUOROCHEM	50,805.08	82.61	6.32	8.31	10.02
Navin Fluorine International Ltd.	NAVINFLUOR	42,046.27	53.24	10.01	20.24	21.39

Epigral Ltd. (EPIGRAL) has a P/E ratio of 17.9x compared with the displayed peer median of 63.22x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.09% compares with a peer median of 20.24% across the companies shown in the table. ROCE stood at 15.65% versus the displayed peer median of 21.39%, providing a capital-efficiency comparison. Epigral Ltd. (EPIGRAL) has a market capitalisation of Rs 4,852.11 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Epigral

• Epigral Ltd. Share Price rose 8.25% today to Rs 1,217.50 from Rs 1,124.70.
• The day’s range was Rs 1,125.05 to Rs 1,223, with turnover of Rs 1.27 crore.
• Market capitalisation stood at Rs 4,852.11 crore during the session.
• P/E of 17.9 is below the chemicals benchmark median of 24.67.
• ROE of 16.09% and ROCE of 15.65% are above the benchmark medians.

About Epigral Ltd.

Epigral Ltd. operates in the Chemicals sector and Chemicals industry. The supplied data does not include a business-segment breakdown, so the company should be viewed here through its verified market and financial profile rather than through a product-level description. What is clear from the dataset is that Epigral has a market capitalisation of Rs 4,852.11 crore, a P/E ratio of 17.9, a P/B ratio of 2.09, ROE of 16.09%, ROCE of 15.65%, EPS of Rs 62.82, book value of Rs 537.91 and dividend yield of 0.44%.

That combination makes the stock relevant for readers looking at Epigral Ltd. Stock News, Epigral Ltd. Financial Results and Epigral Ltd. Company News in one place on Univest. The company’s same-day share price rise is therefore best understood as part of a broader market update that includes valuation, profitability and peer context.

Track Epigral Ltd. Share Price on Univest

Use Epigral Ltd. (EPIGRAL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Frequently Asked Questions

Why did Epigral Ltd. Share Price rise today?

Ans. The data confirms that Epigral Ltd. Share Price rose 8.25% today, but it does not establish a company-specific catalyst. The move is still relevant because it came alongside Rs 1,217.50 pricing and Rs 4,852.11 crore market capitalisation.

What is Epigral Ltd. Share Price today?

Ans. Epigral Ltd. Share Price today is Rs 1,217.50. It was up Rs 92.80, or 8.25%, from the previous close of Rs 1,124.70, making it a notable same-day price rise in the chemicals space.

What was the day’s range for Epigral Ltd. Share Price?

Ans. The stock moved between Rs 1,125.05 and Rs 1,223 during the session. Its open was Rs 1,130.20, which shows the intraday range around the Epigral Ltd. Share Price Today move.

What is Epigral Ltd. market capitalisation?

Ans. Epigral Ltd. market capitalisation stood at Rs 4,852.11 crore. That is above the chemicals industry median market cap in the benchmark set, though below the industry average shown in the supplied data.

How does Epigral compare on valuation?

Ans. Epigral trades at a P/E of 17.9 and P/B of 2.09. The P/E is below the chemicals benchmark median, while the P/B is slightly above the benchmark median and close to the average.

How strong are Epigral’s profitability metrics?

Ans. Epigral reports ROE of 16.09% and ROCE of 15.65%. Both are above the benchmark medians in the chemicals industry set, while EPS is Rs 62.82 and book value is Rs 537.91.

What is Epigral’s dividend yield?

Ans. Epigral’s dividend yield is 0.44%. This is historical or current payout data, not a guarantee of future distributions, and it should be read alongside the stock’s valuation and earnings profile.

How does Epigral compare with chemicals peers?

Ans. Epigral’s P/E of 17.9 is lower than the peer figures supplied for Solar Industries, Pidilite, SRF, Gujarat Fluorochemicals and Navin Fluorine. Its ROE and ROCE are also competitive versus several peers.